Nonetheless, a recent investigation involving 85 ES-SCLC patients with baseline BM demonstrated that anti programmed death ligand 1 (PD-L1) therapy could significantly prolong OS (26). The gene discussed is CD274; the disease is small cell lung carcinoma.